Healthcare and Life Science
A £14.5 Billion Opening: How UK life sciences firms can lead China’s healthcare transformation
On 2 July 2025, China’s Ministry of Finance, National Health Commission, and National Disease Control Administration jointly announced a RMB 20.92 billion (£14.5 billion) Major Public Health Service Subsidy Fund for 2025. This signals a bold continuation of healthcare system modernisati...
A Chinese perspective on England’s “Fit for the Future” NHS plan
In July 2025, England launched its ambitious “Fit for the Future” strategy—a 10-year vision to transform the National Health Service (NHS). By shifting care closer to communities, accelerating digital transformation, and prioritising prevention, the plan addresses the urgent challenges ...
Groundbreaking science celebrated at prestigious technologies competition
Four winners share £100,000 prize pot to take the next steps to commercialising their technology. The winning scientists have developed exciting solutions to some of the biggest challenges we face today, in areas including antimicrobial resistance. ...
Milner Therapeutics Symposium showcases innovation in translational science
Hosted at West Road Concert Hall in Cambridge, the Symposium brings together leading minds from academia and industry to showcase cutting-edge research and its translation into novel therapeutics. ...
Healx and SCI Ventures join forces to uncover cures for paralysis with AI-driven drug discovery
Healx, a pioneer in AI-powered drug discovery for rare and neglected conditions, has partnered with SCI Ventures - the world’s first specialist venture fund focused on curing paralysis- to accelerate the discovery and development of therapies for spinal cord injury (SCI) using artifici...
Optibrium partners with TalTech on EU-Funded PhD Programme to advance sustainable drug discovery
The research will focus on developing faster and more accurate methods for predicting drug metabolism ...
Founding fundraiser says Addenbrooke’s would not be what it is today without financial support of hospital charity
This month, Addenbrooke's Charitable Trust celebrates its 30th birthday. As the official charity for Addenbrooke’s, it funds high-tech equipment, specialist staff, extra comforts and vital research above and beyond what the NHS is able to provide. Here, one of the founding fundraisers, ...
New insights on genetic damage of some chemotherapies could guide future treatments with less harmful side effects
For the first time, scientists have systematically studied the genetic effects of chemotherapy on healthy tissues. Researchers from the Wellcome Sanger Institute, the University of Cambridge, Cambridge University Hospitals NHS Foundation Trust (CUH) and their collaborators analysed bloo...
Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery
Study identifies new metrics to enhance scRNA-seq based virtual cell modellingFoundational paper to drive development of improved virtual cell models for rejuvenation target discoveryCambridge, UK, 1 July 2025: Shift Bioscience (Shift), a biotechnology company uncovering the biolog...
4basebio introduces new branding to reflect next phase of growth enabling development of advanced genetic therapies
4basebio PLC, a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, today (01 July 2025) announced refreshed branding and the launch of its new website, reflecting the company’s continued growth and success in this rapidly advancing field. ...